Eli Lilly Revenue Falls as Sales of Covid-19 Treatment Wane


Eli Lilly & Co. posted a 4% decline in second-quarter income, as a drop in gross sales of the corporate’s Covid-19 antibody therapy and a few older medication offset positive factors in gross sales for newer medication.

The pharmaceutical firm Thursday reiterated its gross sales forecast for the 12 months however minimize its revenue outlook because the stronger U.S. greenback hurts outcomes.


Please enter your comment!
Please enter your name here

Share post:




More like this

Elon Musk Claims Apple Is Threatening to Remove Twitter From App Store

TechTwitter boss assaults iPhone maker and CEO Tim...

Billie Eilish Gushes Over Much Older Boyfriend Jesse Rutherford, The ‘Hottest F**king F**ker Alive’

Lots of Billie Eilish‘s followers could have points with...

COVID lockdown protests sweep across China

COVID lockdown protests sweep throughout China - CBS...

Trump Is So Toxic That Republicans Are Keeping Him Out Of The Georgia Senate Runoff

Republicans are so nervous that Trump would come...